Cita APA

Johansson, E., Nuñez, M., Svedbom, A., Dilla, T., & Hartz, S. (2018). Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain. Clinicoecon Outcomes Res.

Citación estilo Chicago

Johansson, Erin, Mercedes Nuñez, Axel Svedbom, Tatiana Dilla, y Susanne Hartz. "Cost Effectiveness of Ixekizumab Versus Secukinumab in the Treatment of Moderate-to-severe Plaque Psoriasis in Spain." Clinicoecon Outcomes Res 2018.

Cita MLA

Johansson, Erin, et al. "Cost Effectiveness of Ixekizumab Versus Secukinumab in the Treatment of Moderate-to-severe Plaque Psoriasis in Spain." Clinicoecon Outcomes Res 2018.